Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapyJennifer L. Crombie, Michael Dickinson, Yasmin Karimi et al.|Blood|2024Cited by 132
Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?Johan Pallud, Marc Zanello, Alexandre Roux et al.|Journal of Neuro-Oncology|2017Cited by 40